The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 18, 2020

Filed:

Sep. 04, 2014
Applicants:

The University of Tokyo, Tokyo, JP;

Chugai Seiyaku Kabushiki Kaisha, Tokyo, JP;

Inventors:

Hiroyuki Aburatani, Tokyo, JP;

Shumpei Ishikawa, Tokyo, JP;

Miwako Kakiuchi, Tokyo, JP;

Takashi Nishizawa, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); C12N 9/14 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); C12N 9/14 (2013.01); C12N 15/1137 (2013.01); C12N 2310/14 (2013.01); C12N 2320/30 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/178 (2013.01); C12Y 306/05002 (2013.01);
Abstract

Disclosed are a novel method of detecting cancer, a method of screening inhibitors and anticancer agents that target cancer-related molecules, RHOA polypeptide having mutation and a polynucleotide encoding the polypeptide as a therapeutic agent for cancer, and a method of detecting cancer using the polypeptide or polynucleotide. Also disclosed are a vector and a host cell comprising the polynucleotide, a method of screening therapeutic agents for cancer comprising the polypeptide and/or the polynucleotide, and a therapeutic agent for cancer comprising siRNA having a silencing effect on RHOA mutant.


Find Patent Forward Citations

Loading…